EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 81 filers reported holding EIDOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,869,000 | -82.0% | 36,991 | -79.6% | 0.01% | -81.8% |
Q4 2019 | $10,399,000 | +73.6% | 181,200 | +8.8% | 0.06% | +48.6% |
Q3 2019 | $5,989,000 | +736.5% | 166,500 | +220.2% | 0.04% | +1133.3% |
Q4 2018 | $716,000 | +221.1% | 52,000 | +132.4% | 0.00% | +200.0% |
Q3 2018 | $223,000 | -94.6% | 22,376 | -88.9% | 0.00% | -93.8% |
Q2 2018 | $4,104,000 | – | 201,780 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |